Sarepta Plots Multi-Study Label Expansion For Elevidys To Eventually Cover Nearly All DMD Population

 
• By Derrick Gingery
  
Dart and gene therapy
EMBARK data could be sent to the FDA before the application to expand Elevidys label is submitted. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews